Evidence map›Paper›PMID 42434307›Full record

ReviewFrontiers in endocrinology2026

Hyperparathyroidism: current concepts in diagnosis and surgical treatment.

Zhiyuan Wang, Xianqiang Yu

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhiyuan WangDepartment of Thyroid Disease Diagnosis and Treatment, Qingdao Municipal Hospital (Qingdao Hospital of Rehabilitation University), Qingdao, China.
Xianqiang YuDepartment of Thyroid Disease Diagnosis and Treatment, Qingdao Municipal Hospital (Qingdao Hospital of Rehabilitation University), Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperparathyroidism (HPT) is a complex endocrine disorder characterized by the dysregulated secretion of parathyroid hormone (PTH), leading to significant disruptions in calcium and phosphate homeostasis. This review provides a comprehensive analysis of the condition, beginning with the distinct clinical and biochemical profiles of its primary, secondary, and tertiary forms. It critically examines the evolving diagnostic pathways and the refined indications for surgical intervention, which remains the only curative treatment for primary HPT and a crucial therapy for advanced secondary and tertiary disease. Central to the discussion is a detailed exploration of modern surgical strategies, highlighting the paradigm shift from traditional bilateral neck exploration to precision-focused, minimally invasive parathyroidectomy, enabled by advanced preoperative localization and intraoperative PTH monitoring. The review further considers outcomes, postoperative management, and emerging techniques, including remote-access endoscopic approaches. By synthesizing current evidence and guidelines, this work aims to delineate a holistic framework for the effective management of HPT, from accurate diagnosis through to the selection and execution of the optimal surgical treatment strategy.

Indexed as

HyperparathyroidismParathyroidectomyHumansParathyroid HormoneParathyroid Hormonehungry bone syndrome (HBS)hyperparathyroidism (HPT)hypocalcemiaparathyroidectomyparathyroid hormone (PTH)

Identifiers

PMID42434307
PMCPMC13350269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.